Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BMEA |
---|---|---|
09:32 ET | 57773 | 5.582 |
09:34 ET | 13684 | 5.7932 |
09:36 ET | 2833 | 5.78 |
09:38 ET | 2402 | 5.7001 |
09:39 ET | 3146 | 5.76 |
09:41 ET | 8852 | 5.6047 |
09:43 ET | 4872 | 5.68 |
09:45 ET | 11502 | 5.76 |
09:48 ET | 4002 | 5.765 |
09:50 ET | 7133 | 5.7458 |
09:52 ET | 5634 | 5.62 |
09:54 ET | 7039 | 5.63 |
09:56 ET | 10714 | 5.65 |
09:57 ET | 2074 | 5.72 |
09:59 ET | 4877 | 5.69 |
10:01 ET | 10871 | 5.68 |
10:03 ET | 14075 | 5.72 |
10:06 ET | 6550 | 5.72 |
10:08 ET | 19876 | 5.765 |
10:10 ET | 9821 | 5.675 |
10:12 ET | 5679 | 5.72 |
10:14 ET | 3415 | 5.72 |
10:15 ET | 14405 | 5.77 |
10:17 ET | 5365 | 5.745 |
10:19 ET | 1600 | 5.759 |
10:21 ET | 6273 | 5.78 |
10:24 ET | 8795 | 5.83 |
10:26 ET | 19546 | 5.85 |
10:28 ET | 10365 | 5.9094 |
10:30 ET | 3110 | 5.86 |
10:32 ET | 9155 | 5.918 |
10:33 ET | 21123 | 5.9 |
10:35 ET | 28354 | 5.93 |
10:37 ET | 22278 | 5.9911 |
10:39 ET | 36554 | 6 |
10:42 ET | 20362 | 5.995 |
10:44 ET | 9826 | 6.03 |
10:46 ET | 16355 | 6.03 |
10:48 ET | 21467 | 6.085 |
10:50 ET | 30638 | 6.05 |
10:51 ET | 5525 | 6.0222 |
10:53 ET | 15524 | 5.995 |
10:55 ET | 13371 | 6 |
10:57 ET | 32126 | 5.9899 |
11:00 ET | 5366 | 5.995 |
11:02 ET | 30451 | 5.95 |
11:04 ET | 8171 | 5.96 |
11:06 ET | 7860 | 5.97 |
11:08 ET | 6445 | 5.93 |
11:09 ET | 3979 | 5.9518 |
11:11 ET | 5143 | 5.9522 |
11:13 ET | 6812 | 5.97 |
11:15 ET | 8590 | 5.96 |
11:18 ET | 6775 | 6.03 |
11:20 ET | 6520 | 6 |
11:22 ET | 4966 | 6.0195 |
11:24 ET | 4339 | 6.01 |
11:26 ET | 1733 | 6 |
11:27 ET | 1938 | 6.02 |
11:29 ET | 5300 | 6.0378 |
11:31 ET | 4017 | 6.05 |
11:33 ET | 3303 | 6.06 |
11:36 ET | 4184 | 6.08 |
11:38 ET | 15816 | 6.035 |
11:40 ET | 3942 | 6.0143 |
11:42 ET | 12514 | 5.97 |
11:44 ET | 5589 | 5.94 |
11:45 ET | 21573 | 5.91 |
11:47 ET | 6894 | 5.89 |
11:49 ET | 7460 | 5.9 |
11:51 ET | 17487 | 5.91 |
11:54 ET | 8821 | 5.88 |
11:56 ET | 10182 | 5.85 |
11:58 ET | 5406 | 5.86 |
12:00 ET | 3760 | 5.89 |
12:02 ET | 497 | 5.8788 |
12:03 ET | 1037 | 5.87 |
12:05 ET | 2300 | 5.87 |
12:07 ET | 4878 | 5.84 |
12:09 ET | 1331 | 5.84 |
12:12 ET | 1620 | 5.8501 |
12:14 ET | 2535 | 5.88 |
12:16 ET | 3227 | 5.88 |
12:18 ET | 1850 | 5.88 |
12:20 ET | 2248 | 5.88 |
12:21 ET | 300 | 5.87 |
12:23 ET | 1630 | 5.875 |
12:25 ET | 6067 | 5.92 |
12:27 ET | 300 | 5.92 |
12:30 ET | 3729 | 5.91 |
12:32 ET | 1302 | 5.91 |
12:34 ET | 2400 | 5.9197 |
12:36 ET | 8506 | 5.86 |
12:38 ET | 1650 | 5.865 |
12:39 ET | 4719 | 5.8624 |
12:41 ET | 11981 | 5.803 |
12:43 ET | 13286 | 5.8 |
12:45 ET | 7762 | 5.8 |
12:48 ET | 1463 | 5.8 |
12:50 ET | 100 | 5.79 |
12:52 ET | 700 | 5.82 |
12:54 ET | 3623 | 5.8218 |
12:56 ET | 1100 | 5.81 |
12:57 ET | 4140 | 5.805 |
12:59 ET | 7130 | 5.82 |
01:01 ET | 2000 | 5.85 |
01:03 ET | 100 | 5.85 |
01:06 ET | 2987 | 5.83 |
01:08 ET | 100 | 5.84 |
01:10 ET | 6814 | 5.865 |
01:12 ET | 1210 | 5.87 |
01:14 ET | 1092 | 5.87 |
01:15 ET | 2500 | 5.86 |
01:17 ET | 2300 | 5.865 |
01:19 ET | 1702 | 5.86 |
01:21 ET | 2503 | 5.87 |
01:24 ET | 100 | 5.86 |
01:26 ET | 1859 | 5.86 |
01:28 ET | 549 | 5.8699 |
01:30 ET | 8000 | 5.88 |
01:32 ET | 3318 | 5.88 |
01:33 ET | 505 | 5.87 |
01:35 ET | 200 | 5.875 |
01:37 ET | 2549 | 5.87 |
01:39 ET | 1500 | 5.89 |
01:42 ET | 15623 | 5.89 |
01:44 ET | 458 | 5.885 |
01:46 ET | 2900 | 5.91 |
01:48 ET | 10150 | 5.91 |
01:50 ET | 3635 | 5.895 |
01:51 ET | 2233 | 5.905 |
01:53 ET | 5150 | 5.9079 |
01:55 ET | 5826 | 5.841 |
01:57 ET | 11687 | 5.83 |
02:00 ET | 1564 | 5.815 |
02:02 ET | 2770 | 5.84 |
02:04 ET | 10325 | 5.85 |
02:06 ET | 12004 | 5.9065 |
02:08 ET | 1644 | 5.89 |
02:09 ET | 1801 | 5.89 |
02:11 ET | 2302 | 5.92 |
02:13 ET | 1495 | 5.91 |
02:15 ET | 3653 | 5.8968 |
02:18 ET | 1224 | 5.9 |
02:20 ET | 700 | 5.9007 |
02:22 ET | 2375 | 5.9215 |
02:24 ET | 22003 | 5.95 |
02:26 ET | 2614 | 5.94 |
02:27 ET | 5363 | 5.91 |
02:29 ET | 4524 | 5.89 |
02:31 ET | 4146 | 5.89 |
02:33 ET | 1155 | 5.895 |
02:36 ET | 4729 | 5.88 |
02:38 ET | 800 | 5.8807 |
02:40 ET | 1547 | 5.8883 |
02:42 ET | 2522 | 5.88 |
02:44 ET | 1126 | 5.88 |
02:45 ET | 1300 | 5.86 |
02:47 ET | 3403 | 5.85 |
02:49 ET | 4044 | 5.86 |
02:51 ET | 410 | 5.87 |
02:54 ET | 300 | 5.87 |
02:56 ET | 3300 | 5.89 |
02:58 ET | 1500 | 5.9 |
03:00 ET | 1350 | 5.905 |
03:02 ET | 2864 | 5.915 |
03:03 ET | 10382 | 5.9 |
03:05 ET | 100 | 5.895 |
03:07 ET | 4406 | 5.91 |
03:09 ET | 200 | 5.91 |
03:12 ET | 3319 | 5.91 |
03:14 ET | 3901 | 5.915 |
03:16 ET | 1598 | 5.901 |
03:18 ET | 18727 | 5.83 |
03:20 ET | 23214 | 5.71 |
03:21 ET | 65374 | 5.665 |
03:23 ET | 19943 | 5.68 |
03:25 ET | 15462 | 5.705 |
03:27 ET | 8360 | 5.72 |
03:30 ET | 3346 | 5.76 |
03:32 ET | 1400 | 5.781 |
03:34 ET | 5399 | 5.79 |
03:36 ET | 2158 | 5.79 |
03:38 ET | 4279 | 5.77 |
03:39 ET | 7712 | 5.8 |
03:41 ET | 28763 | 5.75 |
03:43 ET | 13467 | 5.72 |
03:45 ET | 25501 | 5.685 |
03:48 ET | 18093 | 5.67 |
03:50 ET | 22325 | 5.64 |
03:52 ET | 44743 | 5.605 |
03:54 ET | 23881 | 5.6 |
03:56 ET | 82883 | 5.71 |
03:57 ET | 31957 | 5.675 |
03:59 ET | 261998 | 5.64 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biomea Fusion Inc | 202.7M | -1.6x | --- |
Ventyx Biosciences Inc | 203.0M | -0.9x | --- |
Rani Therapeutics Holdings Inc | 203.2M | -3.1x | --- |
Design Therapeutics Inc | 209.6M | -3.5x | --- |
Prelude Therapeutics Inc | 214.2M | -2.1x | --- |
Greenwich Lifesciences Inc | 190.1M | -20.5x | --- |
Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of oral covalent small molecules to treat patients with metabolic diseases and genetically defined cancers. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company is utilizing its proprietary FUSION System to discover, design and develop a pipeline of covalent-binding small molecule medicines designed to maximize clinical benefit for patients. Its lead product candidate, BMF-219, is designed to be an oral, potent, and selective covalent inhibitor of menin, built from its FUSION System. It is developing BMF-219 for the treatment of menin regulated or dependent diseases, such as type 1 and type 2 diabetes as well as subtypes of liquid and solid tumors. Its second development candidate, BMF-500, a covalent inhibitor of activating mutations of the FMS-like tyrosine kinase 3 (FLT3).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $202.7M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 35.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.57 |
Book Value | $4.72 |
P/E Ratio | -1.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.